JPH09291282A - Stabilized liquid crystal material and liquid crystal element using the same - Google Patents
Stabilized liquid crystal material and liquid crystal element using the sameInfo
- Publication number
- JPH09291282A JPH09291282A JP8107468A JP10746896A JPH09291282A JP H09291282 A JPH09291282 A JP H09291282A JP 8107468 A JP8107468 A JP 8107468A JP 10746896 A JP10746896 A JP 10746896A JP H09291282 A JPH09291282 A JP H09291282A
- Authority
- JP
- Japan
- Prior art keywords
- group
- liquid crystal
- antioxidant
- light stabilizer
- single bond
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004973 liquid crystal related substance Substances 0.000 title claims abstract description 57
- 239000000463 material Substances 0.000 title claims abstract description 17
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 29
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 25
- 150000001875 compounds Chemical class 0.000 claims abstract description 22
- 239000004611 light stabiliser Substances 0.000 claims abstract description 19
- 239000000203 mixture Substances 0.000 claims abstract description 19
- 229910052731 fluorine Inorganic materials 0.000 claims abstract description 10
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract 2
- -1 monofluoromethyl group Chemical group 0.000 claims description 34
- 238000000034 method Methods 0.000 claims description 12
- 125000001153 fluoro group Chemical group F* 0.000 claims description 9
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 7
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 7
- 125000004642 (C1-C12) alkoxy group Chemical group 0.000 claims description 6
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 claims description 6
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 claims description 6
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 claims description 6
- 230000000087 stabilizing effect Effects 0.000 claims description 6
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 6
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 6
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 claims description 4
- 125000003342 alkenyl group Chemical group 0.000 claims description 4
- 229910052759 nickel Inorganic materials 0.000 claims description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 3
- 150000001412 amines Chemical class 0.000 claims description 3
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 claims description 3
- 239000012965 benzophenone Substances 0.000 claims description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 3
- 229910052717 sulfur Inorganic materials 0.000 claims description 3
- 239000011593 sulfur Substances 0.000 claims description 3
- 150000003852 triazoles Chemical class 0.000 claims description 3
- 125000006539 C12 alkyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 230000003287 optical effect Effects 0.000 claims description 2
- 125000004785 fluoromethoxy group Chemical group [H]C([H])(F)O* 0.000 claims 1
- 125000004955 1,4-cyclohexylene group Chemical group [H]C1([H])C([H])([H])C([H])([*:1])C([H])([H])C([H])([H])C1([H])[*:2] 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 description 10
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 6
- 239000007983 Tris buffer Substances 0.000 description 5
- 238000004811 liquid chromatography Methods 0.000 description 5
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 5
- 239000004983 Polymer Dispersed Liquid Crystal Substances 0.000 description 4
- 125000001841 imino group Chemical group [H]N=* 0.000 description 4
- 239000002530 phenolic antioxidant Substances 0.000 description 4
- 125000006710 (C2-C12) alkenyl group Chemical group 0.000 description 3
- KGRVJHAUYBGFFP-UHFFFAOYSA-N 2,2'-Methylenebis(4-methyl-6-tert-butylphenol) Chemical compound CC(C)(C)C1=CC(C)=CC(CC=2C(=C(C=C(C)C=2)C(C)(C)C)O)=C1O KGRVJHAUYBGFFP-UHFFFAOYSA-N 0.000 description 3
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- ZFSLODLOARCGLH-UHFFFAOYSA-N isocyanuric acid Chemical compound OC1=NC(O)=NC(O)=N1 ZFSLODLOARCGLH-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 3
- DOIRQSBPFJWKBE-UHFFFAOYSA-N phthalic acid di-n-butyl ester Natural products CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 3
- WGKLOLBTFWFKOD-UHFFFAOYSA-N tris(2-nonylphenyl) phosphite Chemical compound CCCCCCCCCC1=CC=CC=C1OP(OC=1C(=CC=CC=1)CCCCCCCCC)OC1=CC=CC=C1CCCCCCCCC WGKLOLBTFWFKOD-UHFFFAOYSA-N 0.000 description 3
- GEBOLIRYJWISTK-UHFFFAOYSA-N 5-pentyl-2-phenylbenzonitrile Chemical group N#CC1=CC(CCCCC)=CC=C1C1=CC=CC=C1 GEBOLIRYJWISTK-UHFFFAOYSA-N 0.000 description 2
- JKIJEFPNVSHHEI-UHFFFAOYSA-N Phenol, 2,4-bis(1,1-dimethylethyl)-, phosphite (3:1) Chemical compound CC(C)(C)C1=CC(C(C)(C)C)=CC=C1OP(OC=1C(=CC(=CC=1)C(C)(C)C)C(C)(C)C)OC1=CC=C(C(C)(C)C)C=C1C(C)(C)C JKIJEFPNVSHHEI-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 2
- 239000012964 benzotriazole Substances 0.000 description 2
- 235000010290 biphenyl Nutrition 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000005262 ferroelectric liquid crystals (FLCs) Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 229940116351 sebacate Drugs 0.000 description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-L sebacate(2-) Chemical compound [O-]C(=O)CCCCCCCCC([O-])=O CXMXRPHRNRROMY-UHFFFAOYSA-L 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 125000000547 substituted alkyl group Chemical group 0.000 description 2
- LVEOKSIILWWVEO-UHFFFAOYSA-N tetradecyl 3-(3-oxo-3-tetradecoxypropyl)sulfanylpropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCCCC LVEOKSIILWWVEO-UHFFFAOYSA-N 0.000 description 2
- RSJKGSCJYJTIGS-UHFFFAOYSA-N undecane Chemical compound CCCCCCCCCCC RSJKGSCJYJTIGS-UHFFFAOYSA-N 0.000 description 2
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 description 1
- FGYJSJUSODGXAR-UHFFFAOYSA-N 1,3,7,9-tetratert-butyl-11-octoxy-5h-benzo[d][1,3,2]benzodioxaphosphocine Chemical compound C1C2=CC(C(C)(C)C)=CC(C(C)(C)C)=C2OP(OCCCCCCCC)OC2=C1C=C(C(C)(C)C)C=C2C(C)(C)C FGYJSJUSODGXAR-UHFFFAOYSA-N 0.000 description 1
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 1
- GXURZKWLMYOCDX-UHFFFAOYSA-N 2,2-bis(hydroxymethyl)propane-1,3-diol;dihydroxyphosphanyl dihydrogen phosphite Chemical compound OP(O)OP(O)O.OCC(CO)(CO)CO GXURZKWLMYOCDX-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- DXCHWXWXYPEZKM-UHFFFAOYSA-N 2,4-ditert-butyl-6-[1-(3,5-ditert-butyl-2-hydroxyphenyl)ethyl]phenol Chemical compound C=1C(C(C)(C)C)=CC(C(C)(C)C)=C(O)C=1C(C)C1=CC(C(C)(C)C)=CC(C(C)(C)C)=C1O DXCHWXWXYPEZKM-UHFFFAOYSA-N 0.000 description 1
- OHUWUMGGWMNUEP-UHFFFAOYSA-N 2,6-ditert-butyl-4-[(2,4,6-trimethylphenyl)methyl]phenol Chemical compound CC1=CC(C)=CC(C)=C1CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 OHUWUMGGWMNUEP-UHFFFAOYSA-N 0.000 description 1
- ROHFBIREHKPELA-UHFFFAOYSA-N 2-[(3,5-ditert-butyl-4-hydroxyphenyl)methyl]prop-2-enoic acid;methane Chemical compound C.CC(C)(C)C1=CC(CC(=C)C(O)=O)=CC(C(C)(C)C)=C1O.CC(C)(C)C1=CC(CC(=C)C(O)=O)=CC(C(C)(C)C)=C1O.CC(C)(C)C1=CC(CC(=C)C(O)=O)=CC(C(C)(C)C)=C1O.CC(C)(C)C1=CC(CC(=C)C(O)=O)=CC(C(C)(C)C)=C1O ROHFBIREHKPELA-UHFFFAOYSA-N 0.000 description 1
- QSRJVOOOWGXUDY-UHFFFAOYSA-N 2-[2-[2-[3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propanoyloxy]ethoxy]ethoxy]ethyl 3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propanoate Chemical compound CC(C)(C)C1=C(O)C(C)=CC(CCC(=O)OCCOCCOCCOC(=O)CCC=2C=C(C(O)=C(C)C=2)C(C)(C)C)=C1 QSRJVOOOWGXUDY-UHFFFAOYSA-N 0.000 description 1
- PFANXOISJYKQRP-UHFFFAOYSA-N 2-tert-butyl-4-[1-(5-tert-butyl-4-hydroxy-2-methylphenyl)butyl]-5-methylphenol Chemical compound C=1C(C(C)(C)C)=C(O)C=C(C)C=1C(CCC)C1=CC(C(C)(C)C)=C(O)C=C1C PFANXOISJYKQRP-UHFFFAOYSA-N 0.000 description 1
- QRLSTWVLSWCGBT-UHFFFAOYSA-N 4-((4,6-bis(octylthio)-1,3,5-triazin-2-yl)amino)-2,6-di-tert-butylphenol Chemical compound CCCCCCCCSC1=NC(SCCCCCCCC)=NC(NC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)=N1 QRLSTWVLSWCGBT-UHFFFAOYSA-N 0.000 description 1
- FURZYCFZFBYJBT-UHFFFAOYSA-N 4-(4-pentylcyclohexyl)benzonitrile Chemical compound C1CC(CCCCC)CCC1C1=CC=C(C#N)C=C1 FURZYCFZFBYJBT-UHFFFAOYSA-N 0.000 description 1
- XXUSEPRYHRDKFV-UHFFFAOYSA-N 4-(4-propylcyclohexyl)benzonitrile Chemical compound C1CC(CCC)CCC1C1=CC=C(C#N)C=C1 XXUSEPRYHRDKFV-UHFFFAOYSA-N 0.000 description 1
- STEYNUVPFMIUOY-UHFFFAOYSA-N 4-Hydroxy-1-(2-hydroxyethyl)-2,2,6,6-tetramethylpiperidine Chemical compound CC1(C)CC(O)CC(C)(C)N1CCO STEYNUVPFMIUOY-UHFFFAOYSA-N 0.000 description 1
- GONPAIMDIMMKMK-UHFFFAOYSA-N 4-[3-carboxy-4-(3,5-ditert-butyl-4-hydroxyphenyl)butyl]sulfanyl-2-[(3,5-ditert-butyl-4-hydroxyphenyl)methyl]butanoic acid Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CC(CCSCCC(CC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)C(O)=O)C(O)=O)=C1 GONPAIMDIMMKMK-UHFFFAOYSA-N 0.000 description 1
- ZGUBOEMAXMRLON-UHFFFAOYSA-N 4-butan-2-yl-2-[1-(5-butan-2-yl-3-tert-butyl-2-hydroxyphenyl)ethyl]-6-tert-butylphenol Chemical compound CC(C)(C)C1=CC(C(C)CC)=CC(C(C)C=2C(=C(C=C(C=2)C(C)CC)C(C)(C)C)O)=C1O ZGUBOEMAXMRLON-UHFFFAOYSA-N 0.000 description 1
- ZVVFVKJZNVSANF-UHFFFAOYSA-N 6-[3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoyloxy]hexyl 3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoate Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CCC(=O)OCCCCCCOC(=O)CCC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)=C1 ZVVFVKJZNVSANF-UHFFFAOYSA-N 0.000 description 1
- ADRNSOYXKABLGT-UHFFFAOYSA-N 8-methylnonyl diphenyl phosphite Chemical compound C=1C=CC=CC=1OP(OCCCCCCCC(C)C)OC1=CC=CC=C1 ADRNSOYXKABLGT-UHFFFAOYSA-N 0.000 description 1
- GHKOFFNLGXMVNJ-UHFFFAOYSA-N Didodecyl thiobispropanoate Chemical compound CCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCC GHKOFFNLGXMVNJ-UHFFFAOYSA-N 0.000 description 1
- MUXOBHXGJLMRAB-UHFFFAOYSA-N Dimethyl succinate Chemical compound COC(=O)CCC(=O)OC MUXOBHXGJLMRAB-UHFFFAOYSA-N 0.000 description 1
- PTHQJSPLRQKBCQ-UHFFFAOYSA-N OP(O)OP(O)O.C(CCCCCCCCCCCCCCCCC)C(O)(C(CO)(CO)CO)CCCCCCCCCCCCCCCCCC.OP(O)OP(O)O.C(C)(C)(C)C1=C(C(=CC=C1)C(C)(C)C)C(O)(C(CO)(CO)CO)C1=C(C=CC=C1C(C)(C)C)C(C)(C)C Chemical compound OP(O)OP(O)O.C(CCCCCCCCCCCCCCCCC)C(O)(C(CO)(CO)CO)CCCCCCCCCCCCCCCCCC.OP(O)OP(O)O.C(C)(C)(C)C1=C(C(=CC=C1)C(C)(C)C)C(O)(C(CO)(CO)CO)C1=C(C=CC=C1C(C)(C)C)C(C)(C)C PTHQJSPLRQKBCQ-UHFFFAOYSA-N 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- STLLXWLDRUVCHL-UHFFFAOYSA-N [2-[1-[2-hydroxy-3,5-bis(2-methylbutan-2-yl)phenyl]ethyl]-4,6-bis(2-methylbutan-2-yl)phenyl] prop-2-enoate Chemical compound CCC(C)(C)C1=CC(C(C)(C)CC)=CC(C(C)C=2C(=C(C=C(C=2)C(C)(C)CC)C(C)(C)CC)OC(=O)C=C)=C1O STLLXWLDRUVCHL-UHFFFAOYSA-N 0.000 description 1
- IORUEKDKNHHQAL-UHFFFAOYSA-N [2-tert-butyl-6-[(3-tert-butyl-2-hydroxy-5-methylphenyl)methyl]-4-methylphenyl] prop-2-enoate Chemical compound CC(C)(C)C1=CC(C)=CC(CC=2C(=C(C=C(C)C=2)C(C)(C)C)OC(=O)C=C)=C1O IORUEKDKNHHQAL-UHFFFAOYSA-N 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- RSOILICUEWXSLA-UHFFFAOYSA-N bis(1,2,2,6,6-pentamethylpiperidin-4-yl) decanedioate Chemical compound C1C(C)(C)N(C)C(C)(C)CC1OC(=O)CCCCCCCCC(=O)OC1CC(C)(C)N(C)C(C)(C)C1 RSOILICUEWXSLA-UHFFFAOYSA-N 0.000 description 1
- GPKQLHLOONCFDY-UHFFFAOYSA-N bis(6-methylheptyl) phenyl phosphite Chemical compound CC(C)CCCCCOP(OCCCCCC(C)C)OC1=CC=CC=C1 GPKQLHLOONCFDY-UHFFFAOYSA-N 0.000 description 1
- SXXILWLQSQDLDL-UHFFFAOYSA-N bis(8-methylnonyl) phenyl phosphite Chemical compound CC(C)CCCCCCCOP(OCCCCCCCC(C)C)OC1=CC=CC=C1 SXXILWLQSQDLDL-UHFFFAOYSA-N 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- GGAUUQHSCNMCAU-UHFFFAOYSA-N butane-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)CC(C(O)=O)C(C(O)=O)CC(O)=O GGAUUQHSCNMCAU-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- IGARGHRYKHJQSM-UHFFFAOYSA-N cyclohexylbenzene Chemical compound C1CCCCC1C1=CC=CC=C1 IGARGHRYKHJQSM-UHFFFAOYSA-N 0.000 description 1
- OGVJEUDMQQIAPV-UHFFFAOYSA-N diphenyl tridecyl phosphite Chemical compound C=1C=CC=CC=1OP(OCCCCCCCCCCCCC)OC1=CC=CC=C1 OGVJEUDMQQIAPV-UHFFFAOYSA-N 0.000 description 1
- PWWSSIYVTQUJQQ-UHFFFAOYSA-N distearyl thiodipropionate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCCCCCCCC PWWSSIYVTQUJQQ-UHFFFAOYSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- SSDSCDGVMJFTEQ-UHFFFAOYSA-N octadecyl 3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 SSDSCDGVMJFTEQ-UHFFFAOYSA-N 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- MFPCPCHVMQLDJN-UHFFFAOYSA-N phenyl ditridecyl phosphite Chemical compound CCCCCCCCCCCCCOP(OCCCCCCCCCCCCC)OC1=CC=CC=C1 MFPCPCHVMQLDJN-UHFFFAOYSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 1
- BOXSVZNGTQTENJ-UHFFFAOYSA-L zinc dibutyldithiocarbamate Chemical compound [Zn+2].CCCCN(C([S-])=S)CCCC.CCCCN(C([S-])=S)CCCC BOXSVZNGTQTENJ-UHFFFAOYSA-L 0.000 description 1
Landscapes
- Liquid Crystal Substances (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、TN(捩れネマテ
ィック)型液晶素子、STN(超捩れネマティック)型
液晶素子、FLCD(強誘電性液晶ディスプレイ)、P
DLC(ポリマー分散型液晶)型液晶素子に代表される
表示素子に用いられる液晶材料の安定化法、及び該安定
化法を用いることにより、安定化された液晶材料並びに
これらの液晶材料を用いた液晶素子に関する。The present invention relates to a TN (twisted nematic) type liquid crystal element, an STN (super twisted nematic) type liquid crystal element, an FLCD (ferroelectric liquid crystal display), and a P type.
A method for stabilizing a liquid crystal material used in a display element represented by a DLC (polymer dispersed liquid crystal) type liquid crystal element, and a liquid crystal material stabilized by using the stabilizing method and these liquid crystal materials are used. Liquid crystal device.
【0002】[0002]
【従来の技術】近年、情報化社会の進展に伴い、各種の
表示素子はマン―マシーンインターフェースの一つとし
て、その重要性がますます高まっている。このような中
で平面ディスプレイ、特に液晶ディスプレイ(LCD)
は、薄型・軽量・低電圧駆動・低消費電力などの特徴を
有していることから急速に普及してきている。液晶ディ
スプレイはその名が示す通り、その表示部分に液晶組成
物を利用しており、液晶組成物はいわば液晶ディスプレ
イの中核を成す構成部品であると言うことが出来る。ま
た、液晶組成物は有機化合物から構成されている。これ
が精密な電気製品に組み込まれていることは液晶組成物
に次のことを要求する。液晶組成物は、液晶ディスプレ
イの製造工程の苛酷な条件に耐え得ることが出来る安定
性を有し、また、製造された液晶ディスプレイが長期に
わたってその優れた性能を安定に示すためには、液晶組
成物もその使用期間に於て物性が変化しない長期安定性
を有することが必要である。即ち、液晶組成物は、液晶
ディスプレイの製造工程にある100℃以上の熱に数時
間耐えなければならず、さらに数千時間から数万時間に
及ぶ使用期間にわたって安定である必要がある。この条
件は、有機化合物である液晶組成物にとって非常に苛酷
であり、優れた特性を有していてもこの安定性の条件を
満足できないために、実際に液晶ディスプレイに使用す
ることの出来る液晶化合物は限られたものになってい
る。一方、情報社会の到来に伴い、液晶表示素子の高性
能化が不可欠になっており、例えば、液晶表示素子の高
速化に対しては、屈折率異方性に優れた液晶材料が必要
とされ、例えば、特開平7−53417号公報には、2. Description of the Related Art In recent years, with the progress of information-oriented society, various display elements are becoming more important as one of man-machine interfaces. Under these circumstances, flat displays, especially liquid crystal displays (LCDs)
Has been rapidly spreading due to its features such as thinness, light weight, low voltage drive, and low power consumption. As its name implies, a liquid crystal display utilizes a liquid crystal composition in its display portion, and it can be said that the liquid crystal composition is, so to speak, a component forming the core of the liquid crystal display. The liquid crystal composition is composed of an organic compound. The fact that it is incorporated into precision electrical products requires the liquid crystal composition to: The liquid crystal composition has stability such that it can withstand the harsh conditions of the manufacturing process of the liquid crystal display, and in order for the manufactured liquid crystal display to stably exhibit its excellent performance over a long period of time, the liquid crystal composition is It is also necessary for a product to have long-term stability in which the physical properties do not change during its use period. That is, the liquid crystal composition must withstand heat of 100 ° C. or higher in the manufacturing process of a liquid crystal display for several hours, and must be stable over a period of use ranging from several thousand hours to several tens of thousands of hours. This condition is extremely severe for a liquid crystal composition that is an organic compound, and even if it has excellent properties, it cannot satisfy this stability condition, and therefore a liquid crystal compound that can be actually used in a liquid crystal display. Are limited. On the other hand, with the advent of the information society, high performance of liquid crystal display elements is indispensable. For example, in order to increase the speed of liquid crystal display elements, a liquid crystal material having excellent refractive index anisotropy is required. For example, in Japanese Patent Laid-Open No. 7-53417,
【0003】[0003]
【化5】 Embedded image
【0004】等、各種の液晶化合物が見い出されてい
る。Various liquid crystal compounds have been found, such as.
【0005】[0005]
【発明が解決しようとする課題】しかしながら、液晶表
示素子の高性能化に伴う各種の液晶化合物又はそれらの
混合物の安定化法については、これ迄に有効な方法は見
い出されていない。However, no effective method has been found so far for stabilizing various liquid crystal compounds or mixtures thereof accompanying the improvement in performance of liquid crystal display devices.
【0006】[0006]
【課題を解決するための手段】本発明者らは、屈折率異
方性に優れた液晶材料に適した液晶化合物又はそれらの
混合物の安定化法について鋭意検討した結果、酸化防止
剤及び/又は光安定剤が有効であることを見い出し、本
発明を完成するに至った。すなわち、下記一般式(1)Means for Solving the Problems The inventors of the present invention have made earnest studies on a method of stabilizing a liquid crystal compound or a mixture thereof suitable for a liquid crystal material having excellent refractive index anisotropy, and as a result, an antioxidant and / or They found that the light stabilizer is effective, and completed the present invention. That is, the following general formula (1)
【0007】[0007]
【化6】 [Chemical 6]
【0008】〔式中、M及びNは、各々独立に,[Wherein M and N are each independently
【0009】[0009]
【化7】 Embedded image
【0010】を表し、Z1 及びZ2 は、各々独立に、単
結合、−O−、−CH2 CH2 −、−COO−又は−O
CO−を表し、X1 、X2 、X3 、X4 、Y1 、Y2 、
Y3 及びY4 は、各々独立にCH、CF又はNを表し、
Wは単結合、−CH2 CH2 −、−CF2 CF2 −、−
CF2 CH2 −、−CH2 CF2 −Wherein Z 1 and Z 2 are each independently a single bond, --O--, --CH 2 CH 2- , --COO-- or --O.
Represents CO-, X 1 , X 2 , X 3 , X 4 , Y 1 , Y 2 ,
Y 3 and Y 4 each independently represent CH, CF or N,
W is a single bond, -CH 2 CH 2 -, - CF 2 CF 2 -, -
CF 2 CH 2 -, - CH 2 CF 2 -
【0011】[0011]
【化8】 Embedded image
【0012】を表し、LはRepresents L, and L is
【0013】[0013]
【化9】 Embedded image
【0014】を表し、a、b、c又はdは、0又は1を
表し、Rは水素原子、フッ素原子、トリフルオロメチル
基、ジフルオロメチル基、モノフルオロメチル基、トリ
フルオロメトキシ基、ジフルオロメトキシ基、モノフル
オロメトキシ基、シアノ基、C1 〜C12アルキル基、C
1 〜C12アルコキシ基、C2 〜C12アルケニル基又はC
2 〜C12アルコキシアルキル基を表し、R’は光学活性
を示す不斉炭素を含んでいてもよいC1 〜C12アルキル
基、C1 〜C12アルコキシ基、C2〜C12アルケニル基
又はC2 〜C12アルコキシアルキル基を表す。また、W
が単結合である場合は、R’はフッ素原子、トリフルオ
ロメチル基、ジフルオロメチル基、モノフルオロメチル
基、トリフルオロメトキシ基、ジフルオロメトキシ基、
モノフルオロメトキシ基又はシアノ基でもよい。〕で示
される化合物又はそれらを少なくとも1種含有する組成
物と、酸化防止剤を少なくとも1種及び/又は光安定剤
を少なくとも1種を混合することを特徴とする液晶材料
の安定化方法及びそれを用いて安定化された液晶材料、
並びに該液晶材料を一対の電極板間に挟持してなる液晶
素子を提供する。以下に本発明について詳しく説明す
る。Represents a, b, c or d represents 0 or 1, and R represents a hydrogen atom, a fluorine atom, a trifluoromethyl group, a difluoromethyl group, a monofluoromethyl group, a trifluoromethoxy group, a difluoromethoxy group. Group, monofluoromethoxy group, cyano group, C 1 -C 12 alkyl group, C
1 -C 12 alkoxy group, C 2 -C 12 alkenyl or C
Represents 2 -C 12 alkoxyalkyl an alkyl group, R 'is an optionally C 1 -C 12 alkyl group optionally contain asymmetric carbon exhibit optical activity, C 1 -C 12 alkoxy group, C 2 -C 12 alkenyl group, or It represents a C 2 -C 12 alkoxyalkyl group. Also, W
Is a single bond, R ′ is a fluorine atom, a trifluoromethyl group, a difluoromethyl group, a monofluoromethyl group, a trifluoromethoxy group, a difluoromethoxy group,
It may be a monofluoromethoxy group or a cyano group. ] The compound shown by these, or the composition containing at least 1 sort (s) thereof, and at least 1 sort (s) of antioxidant and / or at least 1 sort (s) of light stabilizer, and the stabilization method of the liquid crystal material characterized by the above-mentioned. Liquid crystal material, stabilized using
Also provided is a liquid crystal element in which the liquid crystal material is sandwiched between a pair of electrode plates. Hereinafter, the present invention will be described in detail.
【0015】[0015]
【発明の実施の形態】本発明における液晶材料中の酸化
防止剤及び/又は光安定剤の含有率は、0.001〜5
重量%である。BEST MODE FOR CARRYING OUT THE INVENTION The content of the antioxidant and / or the light stabilizer in the liquid crystal material in the present invention is 0.001 to 5
% By weight.
【0016】本発明において酸化防止剤としては、フェ
ノール系酸化防止剤、ホスファイト系酸化防止剤、ホス
フォオイト系酸化防止剤、イオウ系酸化防止剤等が挙げ
られ、光安定剤としては、ヒンダードアミン系光安定
剤、ベンゾフェノン系光安定剤、トリアゾール系光安定
剤、ニッケル系消光剤等が挙げられる。In the present invention, examples of the antioxidant include phenol type antioxidants, phosphite type antioxidants, phosphoite type antioxidants, sulfur type antioxidants, and the like, and examples of the light stabilizer include hindered amine type light stabilizers. Examples thereof include stabilizers, benzophenone-based light stabilizers, triazole-based light stabilizers, and nickel-based quenchers.
【0017】本発明においてフェノール系酸化防止剤と
しては、特に限定されないが、下記の構造を部分構造と
して有する化合物が例示される。 式1In the present invention, the phenolic antioxidant is not particularly limited, but compounds having the following structure as a partial structure are exemplified. Equation 1
【0018】[0018]
【化10】 Embedded image
【0019】〔式中、R1 及びR2 は各々独立に、水素
原子又はアルキル基を表す。〕 好ましい具体例としては、2,6―ジ―t―ブチル―4
―メチルフェノール、オクタデシル―3―(3,5―ジ
―t―ブチル―4―ヒドロキシフェニル)プロピオネー
ト、2,2’―メチレンビス(6―t―ブチル―4―メ
チルフェノール)、2―t―ブチル―6―(3―t―ブ
チル―2―ヒドロキシ―5―メチルベンジル)―4―メ
チルフェニルアクリレート、2―[1―(2―ヒドロキ
シ―3,5―ジ―t―ペンチルフェニル)エチル]―
4,6―ジ―t―ペンチルフェニルアクリレート、4,
4’―ブチリデンビス(6―t―ブチル―3―メチルフ
ェノール)、3,9’―ビス[2―{3―(3―t―ブ
チル―4―ヒドロキシ―5―メチルフェニル)プロピオ
ニルオキシ}―1,1―ジメチルエチル]―2,4,
8,10―テトラオキサスピロ[5・5]ウンデカン、
2―(3,5―ジ―t―ブチル―4―ヒドロキシアニリ
ノ)―4,6―ビス(n―オクチルチオ)―1,3,5
―トリアジン、2,2’―エチリデンビス(4,6―ジ
―t―ブチルフェノール)、2,2’―エチリデンビス
(4―sec―ブチル―6―t―ブチルフェノール)、[In the formula, R 1 and R 2 each independently represent a hydrogen atom or an alkyl group. ] As a preferred specific example, 2,6-di-t-butyl-4
-Methylphenol, octadecyl-3- (3,5-di-t-butyl-4-hydroxyphenyl) propionate, 2,2'-methylenebis (6-t-butyl-4-methylphenol), 2-t-butyl -6- (3-t-Butyl-2-hydroxy-5-methylbenzyl) -4-methylphenyl acrylate, 2- [1- (2-hydroxy-3,5-di-t-pentylphenyl) ethyl]-
4,6-di-t-pentylphenyl acrylate, 4,
4'-butylidene bis (6-t-butyl-3-methylphenol), 3,9'-bis [2- {3- (3-t-butyl-4-hydroxy-5-methylphenyl) propionyloxy} -1 , 1-Dimethylethyl] -2,4
8,10-tetraoxaspiro [5.5] undecane,
2- (3,5-di-t-butyl-4-hydroxyanilino) -4,6-bis (n-octylthio) -1,3,5
-Triazine, 2,2'-ethylidene bis (4,6-di-t-butylphenol), 2,2'-ethylidene bis (4-sec-butyl-6-t-butylphenol),
【0020】2,2’―チオビス(6―t―ブチル―3
―メチルフェノール)、1,1,3―トリス(5―t―
ブチル―4―ヒドロキシ―2―メチルフェニル)ブタ
ン、ビス[2―t―ブチル―4―メチル―6―(3―t
―ブチル―2―ヒドロキシ―5―メチルベンジル)フェ
ニル]テレフタレート、テトラキス[メチレン―3―
(3,5―ジ―t―ブチル―4―ヒドロキシフェニル)
プロピオネート]メタン、2,2’―チオジエチレンビ
ス[3―(3,5―ジ―t―ブチル―4―ヒドロキシフ
ェニル)プロピオネート]、トリエチレングリコールビ
ス[3―(3―t―ブチル―4―ヒドロキシ―5―メチ
ルフェニル)プロピオネート]、1,6―ヘキサンジオ
ールビス[3―(3,5―ジ―t―ブチル―4―ヒドロ
キシフェニル)プロピオネート]、1,3,5―トリス
(3,5―ジ―t―ブチル―4―ヒドロキシベンジル)
イソシアヌレート、1,3,5―トリス[2―{3―
(3,5―ジ―t―ブチル―4―ヒドロキシフェニル)
プロピオニルオキシ}エチル]イソシアヌレート、1,
3,5―トリス(4―t―ブチル―3―ヒドロキシ―
2,6―ジメチルベンジル)イソシアヌレート、1,
3,5―トリス(3,5―ジ―t―ブチル―4―ヒドロ
キシベンジル)―2,4,6―トリメチルベンゼン等が
挙げられる。2,2'-thiobis (6-t-butyl-3)
-Methylphenol), 1,1,3-Tris (5-t-
Butyl-4-hydroxy-2-methylphenyl) butane, bis [2-t-butyl-4-methyl-6- (3-t
-Butyl-2-hydroxy-5-methylbenzyl) phenyl] terephthalate, tetrakis [methylene-3-]
(3,5-di-t-butyl-4-hydroxyphenyl)
Propionate] methane, 2,2'-thiodiethylenebis [3- (3,5-di-t-butyl-4-hydroxyphenyl) propionate], triethyleneglycolbis [3- (3-t-butyl-4- Hydroxy-5-methylphenyl) propionate], 1,6-hexanediolbis [3- (3,5-di-t-butyl-4-hydroxyphenyl) propionate], 1,3,5-tris (3,5) -Di-t-butyl-4-hydroxybenzyl)
Isocyanurate, 1,3,5-Tris [2- {3-
(3,5-di-t-butyl-4-hydroxyphenyl)
Propionyloxy} ethyl] isocyanurate, 1,
3,5-Tris (4-t-butyl-3-hydroxy-
2,6-dimethylbenzyl) isocyanurate, 1,
Examples thereof include 3,5-tris (3,5-di-t-butyl-4-hydroxybenzyl) -2,4,6-trimethylbenzene.
【0021】また、本発明においてイオウ系酸化防止剤
としては、特に限定されないが、下記の式2、式3の化
合物が例示される。 式2In the present invention, the sulfur-based antioxidant is not particularly limited, but compounds represented by the following formulas 2 and 3 are exemplified. Equation 2
【0022】 S−(CH2 CH2 −COOR3)2 (式2) 〔式中、R3 はアルキル基を、好ましくは、C12〜C18
のアルキル基を表す。〕 式3S- (CH 2 CH 2 —COOR 3 ) 2 (Formula 2) [In the formula, R 3 is an alkyl group, preferably C 12 to C 18
Represents an alkyl group. ] Formula 3
【0023】[0023]
【化11】 Embedded image
【0024】〔式中、R4 はアルキル基を、好ましく
は、C12のアルキル基を表す。〕 好ましい具体例としては、ジラウリル 3,3’―チオ
ジプロピオネート、ジミリスチル 3,3’―チオジプ
ロピオネート、ジステアリル 3,3’―チオジプロピ
オネート、テトラキス(3―ラウリルチオプロピオニル
オキシメチル)メタン等が挙げられる。さらに、本発明
においてホスファイト系酸化防止剤及びホスフォオイト
系酸化防止剤としては、特に限定されないが、下記の式
4乃至式9の化合物が例示される。 式4 P−(OR5)3 (式4) 〔式中、R5 は置換されていてもよいアルキル基又はア
リール基を表す。〕 式5及び式6[In the formula, R 4 represents an alkyl group, preferably a C 12 alkyl group. Specific preferred examples include dilauryl 3,3′-thiodipropionate, dimyristyl 3,3′-thiodipropionate, distearyl 3,3′-thiodipropionate, tetrakis (3-laurylthiopropionyloxymethyl) ) Methane and the like. Furthermore, in the present invention, the phosphite-based antioxidant and the phosphite-based antioxidant are not particularly limited, but compounds represented by the following formulas 4 to 9 are exemplified. Equation 4 P- (OR 5) 3 (Formula 4) wherein, R 5 represents an optionally substituted alkyl group or an aryl group. ] Equation 5 and Equation 6
【0025】[0025]
【化12】 [Chemical 12]
【0026】〔式中、R6 は置換されていてもよいアル
キル基又はアリール基を表し、R7、R8 及びR9 は、
各々独立に、水素原子又はC1 〜C8 アルキル基を表
し、R10はフッ素原子又はアルキル基を表し、Xは単結
合、酸素原子又は窒素原子を表す。〕[In the formula, R 6 represents an optionally substituted alkyl group or aryl group, and R 7 , R 8 and R 9 are
Each independently represents a hydrogen atom or a C 1 -C 8 alkyl group, R 10 represents a fluorine atom or an alkyl group, and X represents a single bond, an oxygen atom or a nitrogen atom. ]
【0027】[0027]
【化13】 Embedded image
【0028】〔式中、R11及びR12は、各々独立に、水
素原子又はアルキル基を表し、R13は水素原子又はアル
キル基を表す。但し、R13が水素原子である場合、[In the formula, R 11 and R 12 each independently represent a hydrogen atom or an alkyl group, and R 13 represents a hydrogen atom or an alkyl group. However, when R 13 is a hydrogen atom,
【0029】[0029]
【化14】 Embedded image
【0030】という共鳴構造が存在し、ホスフィネート
化合物になっている。〕 好ましい具体例としては、トリス(ノニルフェニル)
ホスファイト、トリス(2,4―ジ―t―ブチルフェニ
ル) ホスファイト、テトラキス(2,4―ジ―t―ブ
チルフェニル) 4,4’―ビフェニレンジホスフォナ
イト、ビス(2,4―ジ―t―ブチルフェニル) ペン
タエリスリトール ジホスファイト、ビス(2,6―ジ
―t―ブチルフェニル) ペンタエリスリトール ジホ
スファイト ジステアリル ペンタエリスリトール ジホスファイ
ト、フェニル ジイソオクチル ホスファイト、フェニ
ル ジイソデシル ホスファイト、フェニル ジ(トリ
デシル) ホスファイト、ジフェニル イソオクチル
ホスファイト、ジフェニル イソデシル ホスファイ
ト、ジフェニル トリデシル ホスファイト、4,4’
―イソプロピリデンビス(フェニルジアルキル ホスフ
ァイト)、2,2’―メチレンビス(4,6―ジ―t―
ブチルフェニル)オクチル ホスファイト、2,2’―
エチリデンビス(4,6―ジ―t―ブチルフェニル)フ
ルオロホスフォナイト等が挙げられる。本発明において
ヒンダードアミン系光安定剤としては、特に限定されな
いが、下記の構造を部分構造として有する化合物が例示
される。 式10There is a resonance structure of phosphinate compound. ] As a preferable specific example, tris (nonylphenyl)
Phosphite, tris (2,4-di-t-butylphenyl) phosphite, tetrakis (2,4-di-t-butylphenyl) 4,4'-biphenylene diphosphonate, bis (2,4-di) -T-butylphenyl) pentaerythritol diphosphite, bis (2,6-di-t-butylphenyl) pentaerythritol diphosphite distearyl pentaerythritol diphosphite, phenyl diisooctyl phosphite, phenyl diisodecyl phosphite, phenyl di (tridecyl) phosphite, Diphenyl isooctyl
Phosphite, diphenyl isodecyl phosphite, diphenyl tridecyl phosphite, 4,4 '
-Isopropylidene bis (phenyldialkyl phosphite), 2,2'-methylenebis (4,6-di-t-
Butylphenyl) octyl phosphite, 2,2'-
Examples thereof include ethylidene bis (4,6-di-t-butylphenyl) fluorophosphonite. In the present invention, the hindered amine light stabilizer is not particularly limited, but examples thereof include compounds having the following structure as a partial structure. Equation 10
【0031】[0031]
【化15】 Embedded image
【0032】好ましい具体例としては、ビス(2,2,
6,6−テトラメチル−4−ピペリジル) セバケー
ト、ビス(N−メチル−2,2,6,6−テトラメチル
−4−ピペリジル) セバケート、N,N’ビス(2,
2,6,6−テトラメチル−4−ピペリジル)−1,6
−ヘキサメチレンジアミン、2−メチル−2−(2,
2,6,6−テトラメチル−4−ピペリジル)アミノ−
N−(2,2,6,6−テトラメチル−4−ピペリジ
ル)プロピオンアミド、テトラキス(2,2,6,6−
テトラメチル−4−ピペリジル) (1,2,3,4−
ブタンテトラカルボキシレート、ポリ〔{6−(1,
1,3,3−テトラメチルブチル)イミノ−1,3,5
−トリアジン−2,4−ジイル}{(2,2,6,6−
テトラメチル−4−ピペリジル)イミノ}ヘキサメチル
{(2,2,6,6−テトラメチル−4−ピペリジル)
イミノ}〕、ポリ〔(6−モルホリノ−1,3,5−ト
リアジン−2,4−ジイル){(2,2,6,6−テト
ラメチル−4−ピペリジル)イミノ}ヘキサメチン
{(2,2,6,6−テトラメチル−4−ピペリジル)
イミノ}〕、コハク酸ジメチルと 1−(2−ヒドロキ
シエチル)−4−ヒドロキシ−2,2,6,6−テトラ
メチルピペリジンとの重縮合物、N,N’4,7−テト
ラキス〔4,6−ビス{N−ブチル−N−(1,2,
2,6,6−ペンタメチル−4−ピペリジル)アミノ}
−1,3,5−トリアジン−2−イル〕−4,7−ジア
ザデカン−1,10−ジアミン等が挙げられる。本発明
において、ベンゾフェノン系光安定剤としては、特に限
定されないが、下記の構造を部分構造として有する化合
物が例示される。 式11As a preferred specific example, bis (2,2,2
6,6-Tetramethyl-4-piperidyl) sebacate, bis (N-methyl-2,2,6,6-tetramethyl-4-piperidyl) sebacate, N, N ′ bis (2,2
2,6,6-tetramethyl-4-piperidyl) -1,6
-Hexamethylenediamine, 2-methyl-2- (2,
2,6,6-Tetramethyl-4-piperidyl) amino-
N- (2,2,6,6-tetramethyl-4-piperidyl) propionamide, tetrakis (2,2,6,6-
Tetramethyl-4-piperidyl) (1,2,3,4-
Butane tetracarboxylate, poly [{6- (1,
(1,3,3-tetramethylbutyl) imino-1,3,5
-Triazine-2,4-diyl} (2,2,6,6-
Tetramethyl-4-piperidyl) imino} hexamethyl {(2,2,6,6-tetramethyl-4-piperidyl)
Imino}], poly [(6-morpholino-1,3,5-triazine-2,4-diyl) {(2,2,6,6-tetramethyl-4-piperidyl) imino} hexamethine {(2,2 , 6,6-Tetramethyl-4-piperidyl)
Imino}], a polycondensation product of dimethyl succinate and 1- (2-hydroxyethyl) -4-hydroxy-2,2,6,6-tetramethylpiperidine, N, N′4,7-tetrakis [4. 6-bis {N-butyl-N- (1,2,
2,6,6-Pentamethyl-4-piperidyl) amino}
-1,3,5-triazin-2-yl] -4,7-diazadecane-1,10-diamine and the like can be mentioned. In the present invention, the benzophenone-based light stabilizer is not particularly limited, but examples thereof include compounds having the following structure as a partial structure. Equation 11
【0033】[0033]
【化16】 Embedded image
【0034】具体例としては、2,4−ジヒドロキシベ
ンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフ
ェノン等が挙げられる。Specific examples include 2,4-dihydroxybenzophenone and 2-hydroxy-4-methoxybenzophenone.
【0035】本発明において、トリアゾール系光安定剤
としては、特に限定されないが、下記の構造を部分構造
として有する化合物が例示される。 式12In the present invention, the triazole-based light stabilizer is not particularly limited, but compounds having the following structure as a partial structure are exemplified. Equation 12
【0036】[0036]
【化17】 Embedded image
【0037】具体例としては、2−(2−ヒドロキシ−
5−メトキシフェニル)ベンゾトリアゾール、2−(2
−ヒドロキシ−3,5−t−ブチルフェニル)ベンゾト
リアゾール等が挙げられる。本発明において、ニッケル
系消光剤としては、特に限定されないが、基本骨格とし
て有機ニッケル系が挙げられ、具体例としては、ニッケ
ルジブチルジチオカルバメート等が挙げられる。As a specific example, 2- (2-hydroxy-)
5-methoxyphenyl) benzotriazole, 2- (2
-Hydroxy-3,5-t-butylphenyl) benzotriazole and the like. In the present invention, the nickel-based quenching agent is not particularly limited, but an organic nickel-based one is mentioned as a basic skeleton, and specific examples thereof include nickel dibutyldithiocarbamate and the like.
【0038】液晶材料としては、例えば、フッ素置換さ
れていてもよいアルキル基、フッ素置換されていてもよ
いアルケニル基、フッ素置換されていてもよいアルキニ
ル基、フッ素置換されていてもよいアルコキシ基、フッ
素置換されていてもよいアルコキシアルキル基、フッ素
原子若しくはシアノ基を、置換基として有するビフェニ
ル系、同フェニルシクロヘキサン系、同トラン系、同ス
チルベン系又は同ターフェニル系の化合物、又はそれら
の混合物等が挙げられる。さらに、下記の化合物を例示
することができる。Examples of the liquid crystal material include an alkyl group which may be fluorine-substituted, an alkenyl group which may be fluorine-substituted, an alkynyl group which may be fluorine-substituted, an alkoxy group which may be fluorine-substituted, Fluorine-substituted alkoxyalkyl group, fluorine atom or cyano group as a substituent, biphenyl-based, phenylcyclohexane-based, tran-based, stilbene-based or terphenyl-based compounds, or a mixture thereof, etc. Is mentioned. Furthermore, the following compounds can be illustrated.
【0039】[0039]
【化18】 Embedded image
【0040】Rは水素原子、フッ素原子、トリフルオロ
メチル基、ジフルオロメチル基、モノフルオロメチル
基、トリフルオロメトキシ基、ジフルオロメトキシ基、
モノフルオロメトキシ基、シアノ基、C1 〜C12アルキ
ル基、C1 〜C12アルコキシ基、C2 〜C12アルケニル
基又はC2 〜C12アルコキシアルキル基を表し、R’は
C1 〜C12アルキル基、C1 〜C12アルコキシ基、C2
〜C12アルケニル基又はC2 〜C12アルコキシアルキル
基を表し、Wは単結合の場合は、フッ素原子、トリフル
オロメチル基、ジフルオロメチル基、モノフルオロメチ
ル基、トリフルオロメトキシ基、ジフルオロメトキシ
基、モノフルオロメトキシ基又はシアノ基であってもよ
い。また、上記化合物の芳香環はフッ素原子で置換され
ていてもよい。〕R is a hydrogen atom, a fluorine atom, a trifluoromethyl group, a difluoromethyl group, a monofluoromethyl group, a trifluoromethoxy group, a difluoromethoxy group,
Represents a monofluoromethoxy group, a cyano group, a C 1 -C 12 alkyl group, a C 1 -C 12 alkoxy group, a C 2 -C 12 alkenyl group or a C 2 -C 12 alkoxyalkyl group, and R ′ represents C 1 -C. 12 alkyl group, C 1 -C 12 alkoxy group, C 2
To C 12 alkenyl group or C 2 to C 12 alkoxyalkyl group, and when W is a single bond, fluorine atom, trifluoromethyl group, difluoromethyl group, monofluoromethyl group, trifluoromethoxy group, difluoromethoxy group It may be a monofluoromethoxy group or a cyano group. Further, the aromatic ring of the above compound may be substituted with a fluorine atom. ]
【0041】[0041]
【発明の効果】本発明は、TN(捩れネマティック)型
液晶素子、STN(超捩れネマティック)型液晶素子、
FLCD(強誘電性液晶ディスプレイ)、PDLC(ポ
リマー分散型液晶)型液晶素子に代表される表示素子に
用いられる液晶組成物の安定化法として有用である。ま
た、当該安定化法を用いた、安定化された液晶組成物及
びこれらの液晶組成物を用いた液晶素子を提供すること
が出来る。The present invention provides a TN (twisted nematic) type liquid crystal element, an STN (super twisted nematic) type liquid crystal element,
It is useful as a method for stabilizing a liquid crystal composition used in a display device represented by FLCD (ferroelectric liquid crystal display) and PDLC (polymer dispersed liquid crystal) liquid crystal device. Further, it is possible to provide a stabilized liquid crystal composition using the stabilization method and a liquid crystal device using the liquid crystal composition.
【0042】[0042]
【実施例】次に本発明を実施例によりさらに詳しく説明
するが、本発明はこれらの実施例に限定されるものでは
ない。実施例1〜 は、液晶化合物に、酸化防止剤を2
重量%添加し、空気中、暗所で耐熱試験(150℃、2
時間)を行った後、液体クロマトグラフィー(カラムS
UMIPAX QSDA−212 6mmπX15c
m,254nm,MeCNelution)を用いて化
合物の純度を定量した。EXAMPLES Next, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples. In Examples 1 to 2, a liquid crystal compound and an antioxidant were added.
Weight% addition, heat resistance test (150 ℃, 2
Time, and then liquid chromatography (column S)
UMIPAX QSDA-212 6mmπX15c
The purity of the compound was quantified using m, 254 nm, MeC Resolution).
【0043】実施例1 4−(4−ペンチルシクロヘキシル)ベンズニトリル
(5PCH)50mgに、フェノール系酸化防止剤であ
るテトラキス〔メチレン−3−(3,5−ジ−t−ブチ
ル−4−ヒドロキシフェニル)プロピオネート〕メタン
を2重量%添加し、空気中、暗所で耐熱試験(150
℃、2時間)を行い、液体クロマトグラフィーによって
回収率を求めた。比較として酸化防止剤を添加せずに同
様の試験を行った。その結果を表1に示す。Example 1 To 50 mg of 4- (4-pentylcyclohexyl) benznitrile (5PCH) was added tetrakis [methylene-3- (3,5-di-t-butyl-4-hydroxyphenyl), a phenolic antioxidant. ) Propionate] 2% by weight of methane was added, and heat resistance test (150
(° C, 2 hours), and the recovery rate was determined by liquid chromatography. For comparison, the same test was conducted without adding the antioxidant. Table 1 shows the results.
【0044】[0044]
【表1】 [Table 1]
【0045】実施例2 4−ペンチル−シアノビフェニル(5CB)50mg
に、フェノール系酸化防止剤であるテトラキス〔メチレ
ン−3−(3,5−ジ−t−ブチル−4−ヒドロキシフ
ェニル)プロピオネート〕メタンを2重量%添加し、空
気中、暗所で耐熱試験(150℃、2時間)を行い、液
体クロマトグラフィーにより求めた。比較として酸化防
止剤を添加せずに同様の試験を行った。その結果を表2
に示す。Example 2 50 mg of 4-pentyl-cyanobiphenyl (5CB)
2% by weight of tetrakis [methylene-3- (3,5-di-t-butyl-4-hydroxyphenyl) propionate] methane, which is a phenolic antioxidant, was added to, and a heat resistance test in the dark in the air ( It was measured at 150 ° C. for 2 hours and by liquid chromatography. For comparison, the same test was conducted without adding the antioxidant. The results are shown in Table 2.
Shown in
【0046】[0046]
【表2】 [Table 2]
【0047】実施例3〜6 4−(4−プロピルシクロヘキシル)ベンズニトリル
(3PCH)50mgに、酸化防止剤を2重量%添加
し、空気中、暗所で耐熱試験(150℃、2時間)を行
い、液体クロマトグラフィーにより求めた。比較として
酸化防止剤を添加せずに同様の試験を行った。その結果
を表3に示す。また、実施例5と比較例の液体クロマト
グラムを図1及び図2に示す。Examples 3 to 6 To 50 mg of 4- (4-propylcyclohexyl) benznitrile (3PCH), 2% by weight of an antioxidant was added, and a heat resistance test (150 ° C., 2 hours) was conducted in the dark in the air. Performed and determined by liquid chromatography. For comparison, the same test was conducted without adding the antioxidant. Table 3 shows the results. Liquid chromatograms of Example 5 and Comparative Example are shown in FIGS. 1 and 2.
【0048】[0048]
【表3】 [Table 3]
【0049】酸化防止剤 A:ジミリスチル 3,3’−チオジプロピオネート B:トリス(ノニルフェニル) ホスファイト(リン酸
系酸化防止剤)2重量% C/D:2,6−ジ−t−ブチル−4−メチルフェノー
ル(フェノール系酸化防止剤1重量%/トリス(2,4
−ジ−t−ブチルフェニル) ホスファイト(リン酸系
酸化防止剤)1重量% C/B:2,6−ジ−t−ブチル−4−メチルフェノー
ル(フェノール系酸化防止剤1重量%/トリス(ノニル
フェニル) ホスファイト(リン酸系酸化防止剤)1重
量%Antioxidant A: Dimyristyl 3,3'-thiodipropionate B: Tris (nonylphenyl) phosphite (phosphoric acid antioxidant) 2% by weight C / D: 2,6-di-t- Butyl-4-methylphenol (phenolic antioxidant 1% by weight / tris (2,4
-Di-t-butylphenyl) Phosphite (phosphoric acid type antioxidant) 1% by weight C / B: 2,6-di-t-butyl-4-methylphenol (phenolic type antioxidant 1% by weight / Tris (Nonylphenyl) phosphite (phosphoric acid antioxidant) 1% by weight
【0050】実施例7 4−ペンチル−シアノビフェニル(5CB)(300m
g)に、ヒンダードアミン系安息香剤ビス(N−メチル
−2,2,6,6−テトラメチル−4−ピペリジン)セ
バケートを0.2重量%添加した。これをサンプル管に
入れ、島津製作所製耐光性試験機サンテスタXF−18
0にて16時間光照射し、液体クロマトグラフィーによ
り回収率を求めた。比較として光安定剤を添加せずに同
様の試験を行った。その結果を表4に示す。Example 7 4-Pentyl-cyanobiphenyl (5CB) (300 m
To g), 0.2% by weight of hindered amine benzoate bis (N-methyl-2,2,6,6-tetramethyl-4-piperidine) sebacate was added. Put this in a sample tube and make it a Shimadzu light resistance tester Suntester XF-18
It was irradiated with light at 0 for 16 hours, and the recovery rate was determined by liquid chromatography. As a comparison, the same test was conducted without adding the light stabilizer. The results are shown in Table 4.
【0051】[0051]
【表4】 [Table 4]
【図1】実施例5で得られた液体クロマトグラムを示
す。FIG. 1 shows a liquid chromatogram obtained in Example 5.
【図2】実施例3〜6の比較例の液体クロマトグラムを
示す。FIG. 2 shows liquid chromatograms of comparative examples of Examples 3 to 6.
フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 C09K 19/34 C09K 19/34 G02F 1/13 500 G02F 1/13 500 (72)発明者 前田 泰照 茨城県つくば市北原6 住友化学工業株式 会社内 (72)発明者 藤沢 幸一 茨城県つくば市北原6 住友化学工業株式 会社内 (72)発明者 山口 哲夫 茨城県つくば市北原6 住友化学工業株式 会社内Continuation of front page (51) Int.Cl. 6 Identification code Office reference number FI Technical indication location C09K 19/34 C09K 19/34 G02F 1/13 500 G02F 1/13 500 (72) Inventor Maeda Yasuteru Tsukuba, Ibaraki Prefecture Ichi Kitahara 6 Sumitomo Chemical Co., Ltd. (72) Inventor Koichi Fujisawa 6 Tsukuba City, Ibaraki Prefecture Kitahara 6 Sumitomo Chemical Co., Ltd. (72) Inventor Tetsuo Yamaguchi 6 Ibaraki Tsukuba City Kitahara 6 Sumitomo Chemical Co., Ltd.
Claims (6)
−、−CH2 CH2 −、 −COO−又は−OCO−を表し、X1 、X2 、X3 、
X4 、Y1 、Y2 、Y3 及びY4 は、各々独立に,C
H、CF又はNを表し、Wは単結合、−CH2CH
2 −、−CF2 CF2 −、−CF2 CH2 −、−CH2
CF2 − 【化3】 を表し、Lは 【化4】 を表し、a、b、c又はdは、0又は1を表し、Rは水
素原子、フッ素原子、 トリフルオロメチル基、ジフルオロメチル基、モノフル
オロメチル基、トリフルオロメトキシ基、ジフルオロメ
トキシ基、モノフルオロメトキシ基、シアノ基、C1 〜
C12アルキル基、C1 〜C12アルコキシ基、C2 〜C12
アルケニル基又はC2 〜C12アルコキシアルキル基を表
し、R’は光学活性を示す不斉炭素を含んでいてもよい
C1 〜C12アルキル基、C1 〜C12アルコキシ基、C2
〜C12アルケニル基又はC2 〜C12アルコキシアルキル
基を表す。また、Wが単結合である場合は、R’はフッ
素原子、トリフルオロメチル基、ジフルオロメチル基、
モノフルオロメチル基、トリフルオロメトキシ基、ジフ
ルオロメトキシ基、モノフルオロメトキシ基又はシアノ
基でもよい。〕で示される化合物又はそれらを少なくと
も1種含む組成物と、酸化防止剤を少なくとも1種及び
/又は光安定剤を少なくとも1種を混合することを特徴
とする液晶材料の安定化方法。1. The following general formula (1): [Wherein, M and N are each independently And Z 1 and Z 2 are each independently a single bond or —O.
-, - CH 2 CH 2 - , represents -COO- or -OCO-, X 1, X 2, X 3,
X 4 , Y 1 , Y 2 , Y 3 and Y 4 are each independently C
Represents H, CF or N, W is a single bond, —CH 2 CH
2 -, - CF 2 CF 2 -, - CF 2 CH 2 -, - CH 2
CF 2 - ## STR3 ## And L is Represents a, b, c or d represents 0 or 1, R represents a hydrogen atom, a fluorine atom, a trifluoromethyl group, a difluoromethyl group, a monofluoromethyl group, a trifluoromethoxy group, a difluoromethoxy group, a monofluoromethyl group. Fluoromethoxy group, cyano group, C 1 ~
C 12 alkyl group, C 1 -C 12 alkoxy group, C 2 -C 12
Represents an alkenyl group or a C 2 -C 12 alkoxyalkyl group, and R ′ represents a C 1 -C 12 alkyl group which may contain an asymmetric carbon showing optical activity, a C 1 -C 12 alkoxy group, C 2
To C 12 alkenyl group or C 2 to C 12 alkoxyalkyl group. When W is a single bond, R ′ is a fluorine atom, a trifluoromethyl group, a difluoromethyl group,
It may be a monofluoromethyl group, a trifluoromethoxy group, a difluoromethoxy group, a monofluoromethoxy group or a cyano group. ] The compound shown by these or the composition containing at least 1 sort (s) thereof, and at least 1 sort (s) of antioxidant and / or at least 1 sort (s) of light stabilizer are mixed, The stabilizing method of the liquid crystal material characterized by the above-mentioned.
0.001〜5重量%である請求項1記載の方法。2. The method according to claim 1, wherein the content of the antioxidant and / or the light stabilizer is 0.001 to 5% by weight.
剤、、ホスファイト系酸化防止剤、ホスフォイト系酸化
防止剤又はイオウ系酸化防止剤である請求項1記載の方
法。3. The method according to claim 1, wherein the antioxidant is a phenol-based antioxidant, a phosphite-based antioxidant, a phosphite-based antioxidant or a sulfur-based antioxidant.
剤、ベンゾフェノン系光安定剤、トリアゾール系光安定
剤又はニッケル系消光剤である請求項1記載の方法。4. The method according to claim 1, wherein the light stabilizer is a hindered amine light stabilizer, a benzophenone light stabilizer, a triazole light stabilizer or a nickel quencher.
れた液晶材料。5. A liquid crystal material stabilized by the method according to claim 1.
に挟持してなる液晶素子。6. A liquid crystal device comprising the liquid crystal material according to claim 5 sandwiched between a pair of electrode plates.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8107468A JPH09291282A (en) | 1996-04-26 | 1996-04-26 | Stabilized liquid crystal material and liquid crystal element using the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8107468A JPH09291282A (en) | 1996-04-26 | 1996-04-26 | Stabilized liquid crystal material and liquid crystal element using the same |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007062677A Division JP5523657B2 (en) | 2007-03-12 | 2007-03-12 | Stabilized liquid crystal material and liquid crystal element using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH09291282A true JPH09291282A (en) | 1997-11-11 |
Family
ID=14459968
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8107468A Pending JPH09291282A (en) | 1996-04-26 | 1996-04-26 | Stabilized liquid crystal material and liquid crystal element using the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH09291282A (en) |
Cited By (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003226876A (en) * | 2001-10-23 | 2003-08-15 | Clariant Internatl Ltd | Active matrix liquid crystal device and smectic liquid crystal mixture |
JP2004507607A (en) * | 2000-08-30 | 2004-03-11 | クラリアント インターナショナル リミテッド | Liquid crystal mixture |
JP2004315819A (en) * | 2003-04-11 | 2004-11-11 | Merck Patent Gmbh | Liquid crystal medium |
WO2006038443A1 (en) | 2004-10-04 | 2006-04-13 | Chisso Corporation | Liquid crystal composition and liquid crystal display element |
WO2007046384A1 (en) * | 2005-10-18 | 2007-04-26 | Asahi Glass Company, Limited | Liquid crystal light modulation element and optical head device |
EP1785466A1 (en) * | 2005-11-15 | 2007-05-16 | Chisso Corporation | Liquid crystal composition and liquid crystal display device |
JP2007262288A (en) * | 2006-03-29 | 2007-10-11 | Dainippon Ink & Chem Inc | Polymerizable liquid crystal composition |
JP2008248248A (en) * | 2000-12-27 | 2008-10-16 | Dic Corp | Antioxidative liquid crystal composition |
DE102009015692A1 (en) | 2008-04-22 | 2009-10-29 | Merck Patent Gmbh | Liquid crystalline medium |
US7714977B2 (en) | 2004-06-29 | 2010-05-11 | Asahi Glass Company, Limited | Liquid crystal optical modulation element and optical head device |
DE102011013007A1 (en) | 2010-04-01 | 2011-10-06 | Merck Patent Gmbh | Liquid crystalline medium with a nematic phase and a negative dielectric anisotropy, useful in electro-optical displays or components, comprises a substituted cyclic compound and a compound comprising substituted piperidine structural unit |
WO2012076105A1 (en) | 2010-12-07 | 2012-06-14 | Merck Patent Gmbh | Liquid crystal medium and electrooptic display |
WO2012076104A1 (en) | 2010-12-10 | 2012-06-14 | Merck Patent Gmbh | Liquid crystal medium and electrooptic display |
JP2012162742A (en) * | 2012-05-21 | 2012-08-30 | Dic Corp | Polymerizable liquid crystal composition |
EP2514800A2 (en) | 2011-04-21 | 2012-10-24 | Merck Patent GmbH | Compounds and liquid crystalline medium |
DE102012008570A1 (en) | 2011-04-21 | 2012-10-25 | Merck Patent Gmbh | New substituted piperidine compounds are useful in a liquid crystal medium, which is useful in an electro-optical display or electro-optical component, preferably vertical alignment or electrically controlled birefringence display |
EP2722381A2 (en) | 2012-10-18 | 2014-04-23 | Merck Patent GmbH | Liquid crystal medium, method for the stabilisation thereof and liquid crystal display |
EP2722380A2 (en) | 2012-10-18 | 2014-04-23 | Merck Patent GmbH | Liquid crystal medium, method for the stabilisation thereof and liquid crystal display |
CN103969863A (en) * | 2013-01-24 | 2014-08-06 | 三星显示有限公司 | Liquid crystal display device |
WO2015076077A1 (en) | 2013-11-19 | 2015-05-28 | Jnc株式会社 | Piperidine derivative, liquid crystal composition, and liquid crystal display element |
US9107923B2 (en) | 2013-06-27 | 2015-08-18 | Pfizer Inc. | Heteroaromatic compounds and their use as dopamine D1 ligands |
DE10117224B4 (en) * | 2000-04-19 | 2015-12-31 | Merck Patent Gmbh | Process for the stabilization of haloaromatics |
EP2993216A1 (en) | 2014-09-02 | 2016-03-09 | Merck Patent GmbH | Compounds and liquid crystalline medium |
WO2016035667A1 (en) * | 2014-09-05 | 2016-03-10 | Dic株式会社 | Liquid crystal composition and liquid crystal display element using same |
DE102015013980A1 (en) | 2014-11-11 | 2016-05-12 | Merck Patent Gmbh | Heterocyclic compound, liquid-crystalline medium, method for its stabilization and liquid crystal display |
DE102015003602A1 (en) | 2015-03-18 | 2016-09-22 | Merck Patent Gmbh | Liquid crystal medium |
EP3093328A1 (en) | 2015-05-13 | 2016-11-16 | Merck Patent GmbH | Liquid crystalline medium |
JPWO2017038552A1 (en) * | 2015-09-04 | 2017-09-21 | Dic株式会社 | Stabilizer compound, liquid crystal composition, and display element |
EP3279289A1 (en) | 2016-08-05 | 2018-02-07 | Merck Patent GmbH | Piperidine derivatives and liquid crystalline medium |
EP3354710A1 (en) | 2017-01-30 | 2018-08-01 | Merck Patent GmbH | Compounds and liquid crystalline medium |
EP3354709A1 (en) | 2017-01-30 | 2018-08-01 | Merck Patent GmbH | Compounds and liquid crystalline medium |
US10144870B2 (en) | 2004-07-02 | 2018-12-04 | Merck Patent Gmbh | Liquid crystalline medium |
WO2019228938A1 (en) | 2018-05-30 | 2019-12-05 | Merck Patent Gmbh | Compounds and liquid-crystalline medium |
WO2019228939A1 (en) | 2018-05-30 | 2019-12-05 | Merck Patent Gmbh | Compounds and liquid-crystalline medium |
US10633590B2 (en) | 2015-09-04 | 2020-04-28 | Dic Corporation | Liquid crystal composition and liquid crystal display device including the same |
JPWO2023002533A1 (en) * | 2021-07-19 | 2023-01-26 | ||
EP4261269A1 (en) | 2022-04-12 | 2023-10-18 | Merck Patent GmbH | Liquid-crystalline medium |
US11993741B2 (en) | 2019-10-10 | 2024-05-28 | santec Holdings Corporation | Liquid crystal device, optical system, spatial phase modulator, and method of manufacturing liquid crystal device |
-
1996
- 1996-04-26 JP JP8107468A patent/JPH09291282A/en active Pending
Cited By (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10117224B4 (en) * | 2000-04-19 | 2015-12-31 | Merck Patent Gmbh | Process for the stabilization of haloaromatics |
JP2004507607A (en) * | 2000-08-30 | 2004-03-11 | クラリアント インターナショナル リミテッド | Liquid crystal mixture |
JP2008248248A (en) * | 2000-12-27 | 2008-10-16 | Dic Corp | Antioxidative liquid crystal composition |
JP2003226876A (en) * | 2001-10-23 | 2003-08-15 | Clariant Internatl Ltd | Active matrix liquid crystal device and smectic liquid crystal mixture |
JP2004315819A (en) * | 2003-04-11 | 2004-11-11 | Merck Patent Gmbh | Liquid crystal medium |
US7714977B2 (en) | 2004-06-29 | 2010-05-11 | Asahi Glass Company, Limited | Liquid crystal optical modulation element and optical head device |
US10611963B2 (en) | 2004-07-02 | 2020-04-07 | Merck Patent Gmbh | Liquid crystalline medium |
US10533135B2 (en) | 2004-07-02 | 2020-01-14 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Liquid crystalline medium |
US10435626B2 (en) | 2004-07-02 | 2019-10-08 | Merck Patent Gmbh | Liquid crystalline medium |
US10160909B2 (en) | 2004-07-02 | 2018-12-25 | Merck Patent Gmbh | Liquid crystalline medium |
US10150917B2 (en) | 2004-07-02 | 2018-12-11 | Merck Patent Gmbh | Liquid crystalline medium |
US10144870B2 (en) | 2004-07-02 | 2018-12-04 | Merck Patent Gmbh | Liquid crystalline medium |
US7638174B2 (en) | 2004-10-04 | 2009-12-29 | Chisso Corporation | Liquid crystal composition and liquid crystal display element |
WO2006038443A1 (en) | 2004-10-04 | 2006-04-13 | Chisso Corporation | Liquid crystal composition and liquid crystal display element |
JPWO2007046384A1 (en) * | 2005-10-18 | 2009-04-23 | 旭硝子株式会社 | Liquid crystal light modulation element and optical head device |
US7846515B2 (en) | 2005-10-18 | 2010-12-07 | Asahi Glass Company, Limited | Liquid crystal optical modulation element and optical head device |
US8007877B2 (en) | 2005-10-18 | 2011-08-30 | Asahi Glass Company, Limited | Liquid crystal optical modulation element and optical head device |
WO2007046384A1 (en) * | 2005-10-18 | 2007-04-26 | Asahi Glass Company, Limited | Liquid crystal light modulation element and optical head device |
JP5386824B2 (en) * | 2005-10-18 | 2014-01-15 | 旭硝子株式会社 | Liquid crystal light modulation element and optical head device |
KR101368046B1 (en) * | 2005-10-18 | 2014-02-26 | 아사히 가라스 가부시키가이샤 | Liquid crystal light modulation element and optical head device |
US7820250B2 (en) | 2005-10-18 | 2010-10-26 | Asahi Glass Company, Limited | Liquid crystal optical modulation element and optical head device |
US7524540B2 (en) | 2005-11-15 | 2009-04-28 | Chisso Corporation | Liquid crystal composition and liquid crystal display device |
JP2007137921A (en) * | 2005-11-15 | 2007-06-07 | Chisso Corp | Liquid crystal composition and liquid crystal-displaying element |
EP1785466A1 (en) * | 2005-11-15 | 2007-05-16 | Chisso Corporation | Liquid crystal composition and liquid crystal display device |
JP2007262288A (en) * | 2006-03-29 | 2007-10-11 | Dainippon Ink & Chem Inc | Polymerizable liquid crystal composition |
DE102009015692A1 (en) | 2008-04-22 | 2009-10-29 | Merck Patent Gmbh | Liquid crystalline medium |
DE102011013007A1 (en) | 2010-04-01 | 2011-10-06 | Merck Patent Gmbh | Liquid crystalline medium with a nematic phase and a negative dielectric anisotropy, useful in electro-optical displays or components, comprises a substituted cyclic compound and a compound comprising substituted piperidine structural unit |
DE102011117937A1 (en) | 2010-12-07 | 2012-06-14 | Merck Patent Gmbh | Liquid-crystalline medium and electro-optical display |
EP3133137A1 (en) | 2010-12-07 | 2017-02-22 | Merck Patent GmbH | Liquid crystalline medium and electro-optic display |
WO2012076105A1 (en) | 2010-12-07 | 2012-06-14 | Merck Patent Gmbh | Liquid crystal medium and electrooptic display |
WO2012076104A1 (en) | 2010-12-10 | 2012-06-14 | Merck Patent Gmbh | Liquid crystal medium and electrooptic display |
EP2514800A2 (en) | 2011-04-21 | 2012-10-24 | Merck Patent GmbH | Compounds and liquid crystalline medium |
DE102012008570A1 (en) | 2011-04-21 | 2012-10-25 | Merck Patent Gmbh | New substituted piperidine compounds are useful in a liquid crystal medium, which is useful in an electro-optical display or electro-optical component, preferably vertical alignment or electrically controlled birefringence display |
JP2016166240A (en) * | 2011-04-21 | 2016-09-15 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung | Compound and liquid-crystalline medium |
US9920248B2 (en) | 2011-04-21 | 2018-03-20 | Merck Patent Gmbh | Compounds and liquid-crystalline medium |
JP2012162742A (en) * | 2012-05-21 | 2012-08-30 | Dic Corp | Polymerizable liquid crystal composition |
EP2722381A2 (en) | 2012-10-18 | 2014-04-23 | Merck Patent GmbH | Liquid crystal medium, method for the stabilisation thereof and liquid crystal display |
DE102013017174A1 (en) | 2012-10-18 | 2014-04-24 | Merck Patent Gmbh | Liquid-crystalline medium, method for its stabilization and liquid-crystal display |
EP2722380A2 (en) | 2012-10-18 | 2014-04-23 | Merck Patent GmbH | Liquid crystal medium, method for the stabilisation thereof and liquid crystal display |
DE102013017173A1 (en) | 2012-10-18 | 2014-04-24 | Merck Patent Gmbh | Liquid-crystalline medium, method for its stabilization and liquid-crystal display |
EP3327103A1 (en) | 2012-10-18 | 2018-05-30 | Merck Patent GmbH | Liquid crystal medium, method for the stabilisation thereof and liquid crystal display |
CN103969863A (en) * | 2013-01-24 | 2014-08-06 | 三星显示有限公司 | Liquid crystal display device |
US10093655B2 (en) | 2013-06-27 | 2018-10-09 | Pfizer Inc. | Heteroaromatic compounds and their use as dopamine D1 ligands |
US10421744B2 (en) | 2013-06-27 | 2019-09-24 | Pfizer Inc. | Heteroaromatic compounds and their use as dopamine D1 ligands |
US9139561B2 (en) | 2013-06-27 | 2015-09-22 | Pfizer Inc. | Heteroaromatic compounds and their use as dopamine D1 ligands |
US9822097B2 (en) | 2013-06-27 | 2017-11-21 | Pfizer Inc. | Heteroaromatic compounds and their use as dopamine D1 ligands |
US11964961B2 (en) | 2013-06-27 | 2024-04-23 | Pfizer Inc. | Heteroaromatic compounds and their use as dopamine D1 ligands |
US9107923B2 (en) | 2013-06-27 | 2015-08-18 | Pfizer Inc. | Heteroaromatic compounds and their use as dopamine D1 ligands |
US10696658B2 (en) | 2013-06-27 | 2020-06-30 | Pfizer Inc. | Heteroaromatic compounds and their use as dopamine D1 ligands |
US11014909B2 (en) | 2013-06-27 | 2021-05-25 | Pfizer Inc. | Heteroaromatic compounds and their use as dopamine D1 ligands |
WO2015076077A1 (en) | 2013-11-19 | 2015-05-28 | Jnc株式会社 | Piperidine derivative, liquid crystal composition, and liquid crystal display element |
US10053425B2 (en) | 2013-11-19 | 2018-08-21 | Jnc Corporation | Piperidine derivative, liquid crystal composition and liquid crystal display device |
KR20160088285A (en) | 2013-11-19 | 2016-07-25 | 제이엔씨 주식회사 | Piperidine derivative, liquid crystal composition, and liquid crystal display element |
EP2993216A1 (en) | 2014-09-02 | 2016-03-09 | Merck Patent GmbH | Compounds and liquid crystalline medium |
WO2016035667A1 (en) * | 2014-09-05 | 2016-03-10 | Dic株式会社 | Liquid crystal composition and liquid crystal display element using same |
DE102015013980A1 (en) | 2014-11-11 | 2016-05-12 | Merck Patent Gmbh | Heterocyclic compound, liquid-crystalline medium, method for its stabilization and liquid crystal display |
DE102015003602A1 (en) | 2015-03-18 | 2016-09-22 | Merck Patent Gmbh | Liquid crystal medium |
EP3093328A1 (en) | 2015-05-13 | 2016-11-16 | Merck Patent GmbH | Liquid crystalline medium |
DE102016005083A1 (en) | 2015-05-13 | 2016-11-17 | Merck Patent Gmbh | Liquid crystalline medium |
US9822302B2 (en) | 2015-05-13 | 2017-11-21 | Merck Patent Gmbh | Liquid-crystalline medium |
JP2018123132A (en) * | 2015-09-04 | 2018-08-09 | Dic株式会社 | Stabilizer compound, liquid crystal composition, and display element |
US10329252B2 (en) | 2015-09-04 | 2019-06-25 | Dic Corporation | Stabilizer compound, liquid crystal composition, and display element |
US10633590B2 (en) | 2015-09-04 | 2020-04-28 | Dic Corporation | Liquid crystal composition and liquid crystal display device including the same |
CN107835802B (en) * | 2015-09-04 | 2022-04-22 | Dic株式会社 | Stabilizer compound, liquid crystal composition and display element |
CN107835802A (en) * | 2015-09-04 | 2018-03-23 | Dic株式会社 | Stabilizer compounds, liquid-crystal composition and display element |
JPWO2017038552A1 (en) * | 2015-09-04 | 2017-09-21 | Dic株式会社 | Stabilizer compound, liquid crystal composition, and display element |
DE102017006567A1 (en) | 2016-08-05 | 2018-02-08 | Merck Patent Gmbh | Piperidin derivatives and liquid crystals |
EP3279289A1 (en) | 2016-08-05 | 2018-02-07 | Merck Patent GmbH | Piperidine derivatives and liquid crystalline medium |
EP3354710A1 (en) | 2017-01-30 | 2018-08-01 | Merck Patent GmbH | Compounds and liquid crystalline medium |
US10907100B2 (en) | 2017-01-30 | 2021-02-02 | Merck Patent Gmbh | Compounds and liquid-crystalline medium |
US10913897B2 (en) | 2017-01-30 | 2021-02-09 | Merck Patent Gmbh | Compounds and liquid-crystalline medium |
DE102018000109A1 (en) | 2017-01-30 | 2018-08-02 | Merck Patent Gmbh | Compounds and liquid-crystalline medium |
EP3354709A1 (en) | 2017-01-30 | 2018-08-01 | Merck Patent GmbH | Compounds and liquid crystalline medium |
WO2019228939A1 (en) | 2018-05-30 | 2019-12-05 | Merck Patent Gmbh | Compounds and liquid-crystalline medium |
WO2019228938A1 (en) | 2018-05-30 | 2019-12-05 | Merck Patent Gmbh | Compounds and liquid-crystalline medium |
US11993741B2 (en) | 2019-10-10 | 2024-05-28 | santec Holdings Corporation | Liquid crystal device, optical system, spatial phase modulator, and method of manufacturing liquid crystal device |
JPWO2023002533A1 (en) * | 2021-07-19 | 2023-01-26 | ||
WO2023002533A1 (en) * | 2021-07-19 | 2023-01-26 | サンテック株式会社 | Liquid crystal device, optical system, spatial phase modulator, and liquid crystal device manufacturing method |
EP4261269A1 (en) | 2022-04-12 | 2023-10-18 | Merck Patent GmbH | Liquid-crystalline medium |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH09291282A (en) | Stabilized liquid crystal material and liquid crystal element using the same | |
KR102346467B1 (en) | Liquid crystal composition, liquid crystal display element, liquid crystal display device | |
CN103834414B (en) | Liquid crystal medium, stabilizing method thereof and liquid crystal display | |
TWI553100B (en) | Liquid-crystalline medium | |
JP2002256267A (en) | Antioxidative liquid crystal composition | |
JP2016166240A (en) | Compound and liquid-crystalline medium | |
CN111892935A (en) | Liquid crystal medium, stabilizing method thereof and liquid crystal display | |
KR20070102452A (en) | Liquid-crystalline medium | |
EP0825176B1 (en) | Azine derivative, process for the preparation thereof, nematic liquid crystal composition and liquid crystal display system comprising same | |
JP3904094B2 (en) | Nematic liquid crystal composition and liquid crystal display device using the same | |
JP6986334B2 (en) | Liquid crystal medium | |
CN107667159B (en) | Liquid-crystalline medium | |
CN107686462B (en) | Piperidine derivatives and liquid-crystalline medium | |
KR101790731B1 (en) | Liquid crystal composition and liquid crystal display device | |
JP5523657B2 (en) | Stabilized liquid crystal material and liquid crystal element using the same | |
JP2010180266A (en) | Stabilization method of liquid crystal material and liquid crystal device obtained using the same | |
TW570974B (en) | Liquid-crystalline mixtures | |
KR101109529B1 (en) | Liquid crystal composition | |
JP5077029B2 (en) | Antioxidant liquid crystal composition | |
JPH09151376A (en) | Nematic liquid crystal composition and liquid crystal display using the same | |
EP0393636B1 (en) | Liquid crystal composition and liquid crystal display using said composition | |
JP4385415B2 (en) | Nematic liquid crystal composition and liquid crystal display device using the same | |
JP3899560B2 (en) | Nematic liquid crystal composition and liquid crystal display device using the same | |
JPH0959632A (en) | Nematic liquid crystal composition and liquid crystal display using the same | |
JP3593721B2 (en) | Nematic liquid crystal composition and liquid crystal display device using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060912 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20061211 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20061214 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070312 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070417 |